These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31442849)

  • 1. The countervailing forces behind France's low Ritalin consumption.
    Vallée M
    Soc Sci Med; 2019 Oct; 238():112492. PubMed ID: 31442849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescription of methylphenidate for children: importance of recommendations to limit misuse].
    Chéron-Blümel A; Grall-Bronnec M; Victorri-Vigneau C; Péron E; Bétaud C; Jolliet P; Amar M
    Arch Pediatr; 2014 Aug; 21(8):852-9. PubMed ID: 24974233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmethylphenidate--Novartis/Celgene. Focalin, D-MPH, D-methylphenidate hydrochloride, D-methylphenidate, dexmethylphenidate, dexmethylphenidate hydrochloride.
    Drugs R D; 2002; 3(4):279-82. PubMed ID: 12455205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doing Ritalin right. Sure, it works--but there are big flaws in the way it's being given.
    Brink S
    US News World Rep; 1998 Nov; 125(20):76-7, 80-1. PubMed ID: 10187350
    [No Abstract]   [Full Text] [Related]  

  • 5. [Utilization of methylphenidate(Ritalin) in France].
    Frances C; Hoizey G; Millart H; Trenque T
    Therapie; 2002; 57(2):189-93. PubMed ID: 12185970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder: monitoring in biological matrices].
    Papaseit E; García-Algar O; Simó S; Pichini S; Farré M
    An Pediatr (Barc); 2013 Feb; 78(2):123.e1-10. PubMed ID: 23063334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-release methylphenidate (Ritalin LA).
    Lyseng-Williamson KA; Keating GM
    Drugs; 2002; 62(15):2251-9; discussion 2260-1. PubMed ID: 12381228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day.
    Lopez F; Silva R; Pestreich L; Muniz R
    Paediatr Drugs; 2003; 5(8):545-55. PubMed ID: 12895137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    Steinhausen HC; Bisgaard C
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperactivity and prescription of Ritalin in the canton of Vaud (Switzerland), 2002].
    Huissoud T; Jeannin A; Dubois-Arber F
    Rev Epidemiol Sante Publique; 2007 Oct; 55(5):357-63. PubMed ID: 17889474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T; Rohde LA; Hutz MH
    Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US parents sue psychiatrists for promoting Ritalin.
    Charatan F
    BMJ; 2000 Sep; 321(7263):723. PubMed ID: 10999893
    [No Abstract]   [Full Text] [Related]  

  • 14. [Attention deficit hyperactivity disorder: pharmacological options that are not "Ritalin"].
    Shmueli D; Gross-Tsur V
    Harefuah; 2005 Aug; 144(8):572-6, 597. PubMed ID: 16146157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
    Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
    Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
    Contini V; Rovaris DL; Victor MM; Grevet EH; Rohde LA; Bau CH
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):555-60. PubMed ID: 22709890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.
    Schweren LJ; de Zeeuw P; Durston S
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1151-64. PubMed ID: 23165220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Massive variation in Ritalin prescribing.
    Gainsbury S
    Health Serv J; 2008 Jul; ():5. PubMed ID: 18705035
    [No Abstract]   [Full Text] [Related]  

  • 20. Sleep and daytime sleepiness in methylphenidate medicated and un-medicated children with attention-deficit/hyperactivity disorder (ADHD).
    Cockcroft K; Ashwal J; Bentley A
    Afr J Psychiatry (Johannesbg); 2009 Nov; 12(4):275-9. PubMed ID: 20033109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.